No photo of Sirpa Tenhola

Sirpa Tenhola

20182019
If you made any changes in Pure these will be visible here soon.

Personal profile

External positions

Kymenlaakso Central Hospital

International and National Collaboration Publications and projects within past five years.

Publications 2018 2019

Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children

Seppa, S., Tenhola, S. & Voutilainen, R., Apr 2019, In : Journal of the Endocrine Society. 3, 4, p. 825-837 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial

Varimo, T., Huopio, H., Kariola, L., Tenhola, S., Voutilainen, R., Toppari, J., Toiviainen-Salo, S., Hämäläinen, E., Pulkkinen, M-A., Lääperi, M., Tarkkanen, A., Vaaralahti, K., Miettinen, P. J., Hero, M. & Raivio, T., Feb 2019, In : Lancet child & adolescent health. 3, 2, p. 109-120 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Serum IL-1 Receptor Antagonist Concentrations Associate With Unfavorable Metabolic Features in 12-Year-Old Children

Seppa, S., Tenhola, S. & Voutilainen, R., Aug 2018, In : Journal of the Endocrine Society. 2, 8, p. 870-881 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File